7.79美元0.04(0.52%)
2025/02/12更新
績效 / 1月4.56%
3月2.99%
1年0.52%
晨星評等-
- 1.現金6.63%
- 2.股票14.53%
- 3.債券0.00%
- 4.其他78.84%
- 1.美國79.12%
- 2.已開發亞洲6.96%
- 3.英國4.05%
- 4.日本1.87%
- 5.歐元區1.09%
- 1.Eli Lilly and Co8.09%
- 2.Intuitive Surgical Inc5.94%
- 3.Gilead Sciences Inc5.46%
- 4.Lotus Pharmaceutical Co Ltd4.70%
- 5.Regeneron Pharmaceuticals Inc4.35%
- 6.Thermo Fisher Scientific Inc4.32%
- 7.Boston Scientific Corp4.06%
- 8.AbbVie Inc3.76%
- 9.SPDR® S&P Biotech ETF3.43%
- 10.AstraZeneca PLC ADR3.13%
- 1.現金6.63%
- 2.股票14.53%
- 3.債券0.00%
- 4.其他78.84%
- 1.美國79.12%
- 2.已開發亞洲6.96%
- 3.英國4.05%
- 4.日本1.87%
- 5.歐元區1.09%
- 1.Eli Lilly and Co8.09%
- 2.Intuitive Surgical Inc5.94%
- 3.Gilead Sciences Inc5.46%
- 4.Lotus Pharmaceutical Co Ltd4.70%
- 5.Regeneron Pharmaceuticals Inc4.35%
- 6.Thermo Fisher Scientific Inc4.32%
- 7.Boston Scientific Corp4.06%
- 8.AbbVie Inc3.76%
- 9.SPDR® S&P Biotech ETF3.43%
- 10.AstraZeneca PLC ADR3.13%